Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles

References

• PautlerMBrennerSNanomedicine: promises and challenges for the future of public healthInt J Nanomedicine2010580380921042425
   PubMed Web of Science ®Google Scholar
• Ferrer-MirallesNVazquezEVillaverdeAMembrane-active peptides for non-viral gene therapy: making the safest easierTrends Biotechnol20082626727518358551
   PubMed Web of Science ®Google Scholar
• MillettiFCell-penetrating peptides: classes, origin, and current landscapeDrug Discov Today3232012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• PeledAWaldOBurgerJDevelopment of novel CXCR4-based therapeuticsExpert Opin Investig Drugs201221341353
   PubMed Web of Science ®Google Scholar
• WilenCBTiltonJCDomsRWMolecular mechanisms of HIV entryAdv Exp Med Biol201272622324222297516
   PubMed Web of Science ®Google Scholar
• KlonischTWiechecEHombach-KlonischSCancer stem cell markers in common cancers – therapeutic implicationsTrends Mol Med20081445046018775674
   PubMed Web of Science ®Google Scholar
• SunXChengGHaoMCXCL12/CXCR4/CXCR7 chemokine axis and cancer progressionCancer Metastasis Rev20102970972220839032
   PubMed Web of Science ®Google Scholar
• KimJMoriTChenSLChemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcomeAnn Surg200624411312016794396
   PubMed Web of Science ®Google Scholar
• LiangZYoonYVotawJGoodmanMMWilliamsLShimHSilencing of CXCR4 blocks breast cancer metastasisCancer Res20056596797115705897
   PubMed Web of Science ®Google Scholar
• LiangXCXCR4, inhibitors and mechanisms of actionChem Biol Drug Des2008729711018624812
   PubMed Web of Science ®Google Scholar
• MurakamiTZhangTYKoyanagiYInhibitory mechanism of the CXCR4 antagonist t22 against human immunodeficiency virus type 1 infectionJ Virol1999737489749610438838
   PubMed Web of Science ®Google Scholar
• BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem197672248254942051
   PubMed Web of Science ®Google Scholar
• VazquezERoldanMDíez-GilCProtein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptideNanomedicine (Lond)2010525926820148637
   PubMed Web of Science ®Google Scholar
• VazquezECubarsiRUnzuetaUInternalization and kinetics of nuclear migration of protein-only, arginine-rich nanoparticlesBiomaterials2010319333933920869766
   PubMed Web of Science ®Google Scholar
• Seras-FranzosoJDíez-GilCVazquezEBioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineeringNanomedicine (Lond)20127799322142409
   PubMed Web of Science ®Google Scholar
• BarberaVMMartinMMarinosoLThe 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expressionBiochim Biophys Acta2000150228329611040453
   PubMed Web of Science ®Google Scholar
• BaigMSManickamNHomology modeling and docking studies of Comamonas testosteroni B-356 biphenyl-2,3-dioxygenase involved in degradation of polychlorinated biphenylsInt J Biol Macromol201046475319879892
   PubMed Web of Science ®Google Scholar
• CespedesMVEspinaCGarcia-CabezasMAOrthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sitesAm J Pathol20071701077108517322390
   PubMed Web of Science ®Google Scholar
• AmaraAGallSLSchwartzOHIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replicationJ Exp Med19971861391469207008
   PubMed Web of Science ®Google Scholar
• ZhouNMLuoZWLuoJSHallJWHuangZWA novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-IIBiochemistry2000393782378710736178
   PubMed Web of Science ®Google Scholar
• FujiiNNakashimaHTamamuraHThe therapeutic potential of CXCR4 antagonists in the treatment of HIVExpert Opin Investig Drugs200312185195
   PubMed Web of Science ®Google Scholar
• Ferrer-MirallesNCorcheroJLKumarPBiological activities of histidine-rich peptides; merging biotechnology and nanomedicineMicrob Cell Fact20111010122136342
   PubMed Web of Science ®Google Scholar
• KuciaMJankowskiKRecaRCXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesionJ Mol Histol20043523324515339043
   PubMed Web of Science ®Google Scholar
• Toledo-RubioVVazquezEPlatasGProtein aggregation and soluble aggregate formation screened by a fast microdialysis assayJ Biomol Screen20101545345720233904
   PubMedGoogle Scholar
• Domingo-EspinJVazquezEGanzJThe nanoparticulate architecture of protein-based artificial viruses is supported by protein- DNA interactionsNanomedicine (Lond)201161047106121651444
   PubMed Web of Science ®Google Scholar
• VazquezECorcheroJLVillaverdeAPost-production protein stability: trouble beyond the cell factoryMicrob Cell Fact2011106021806813
   PubMed Web of Science ®Google Scholar
• Martinez-AlonsoMGonzalez-MontalbanNGarcia-FruitosEVillaverdeAThe functional quality of soluble recombinant polypeptides produced in Escherichia coli is defined by a wide conformational spectrumAppl Environ Microbiol200810113531358
   Google Scholar
• RiehemannKSchneiderSWLugerTAGodinBFerrariMFuchsHNanomedicine – challenge and perspectivesAngew Chem Int Ed Engl20094887289719142939
   PubMed Web of Science ®Google Scholar
• DietzGPBahrMDelivery of bioactive molecules into the cell: the Trojan horse approachMol Cell Neurosci2004278513115485768
   PubMed Web of Science ®Google Scholar
• DuncanRGasparRNanomedicine(s) under the microscopeMol Pharm201182101214121974749
   PubMed Web of Science ®Google Scholar
• ThurberGMSchmidtMMWittrupKDFactors determining antibody distribution in tumorsTrends Pharmacol Sci200829576118179828
   PubMed Web of Science ®Google Scholar
• EllisLMHicklinDJResistance to targeted therapies: refining anticancer therapy in the era of molecular oncologyClin Cancer Res2009157471747820008847
   PubMed Web of Science ®Google Scholar
• JainMVenkatramanGBatraSKOptimization of radioimmunotherapy of solid tumors: biological impediments and their modulationClin Cancer Res2007131374138217309914
   PubMed Web of Science ®Google Scholar
• LaakkonenPVuorinenKHoming peptides as targeted delivery vehiclesIntegr Biol (Camb)2010232633720657951
   PubMed Web of Science ®Google Scholar
• EnbackJLaakkonenPTumour-homing peptides: tools for targeting, imaging and destructionBiochem Soc Trans20073578078317635147
   PubMed Web of Science ®Google Scholar
• MocellinSLiseMNittiDTargeted therapy for colorectal cancer: mapping the wayTrends Mol Med20051132733515950539
   PubMed Web of Science ®Google Scholar
• RusconiSScozzafavaAMastrolorenzoASupuranCTAn update in the development of HIV entry inhibitorsCurr Top Med Chem200771273128917627557
   PubMed Web of Science ®Google Scholar
• SegalNHSaltzLBEvolving treatment of advanced colon cancerAnnu Rev Med20096020721919630571
   PubMed Web of Science ®Google Scholar
• EgorovaAKiselevAHakliMRuponenMBaranovVUrttiAChemokine-derived peptides as carriers for gene delivery to CXCR4 expressing cellsJ Gene Med20091177278119562713
   PubMed Web of Science ®Google Scholar
• SleemanJSteegPSCancer metastasis as a therapeutic targetEur J Cancer2010461177118020307970
   PubMed Web of Science ®Google Scholar
• SkipperHESchabelFMJrMellettLBImplications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedulesCancer Chemother Rep1970544314505527023
   PubMedGoogle Scholar
• VillaverdeANanotechnology, bionanotechnology and microbial cell factoriesMicrob Cell Fact201095320602780
   PubMed Web of Science ®Google Scholar
• VazquezEVillaverdeAEngineering building blocks for self- assembling protein nanoparticlesMicrob Cell Fact2010910121192790
   PubMed Web of Science ®Google Scholar
• SadatmousaviPSoltaniMNazarianRJafariMChenPSelf-assembling peptides: potential role in tumor targetingCurr Pharm Biotechnol2011121089110021470142
   PubMed Web of Science ®Google Scholar
• ZhaoYTanakaMKinoshitaTHiguchiMTanTSelf-assembling peptide nanofiber scaffolds for controlled release governed by gelator design and guest sizeJ Control Release201014739239920709121
   PubMed Web of Science ®Google Scholar
• KyleSAggeliAInghamEMcPhersonMJRecombinant self- assembling peptides as biomaterials for tissue engineeringBiomaterials2010319395940520932572
   PubMed Web of Science ®Google Scholar
• HuangHSunXSRational design of responsive self-assembling peptides from native protein sequences (dagger)Biomacromolecules2010113390339421080625
   PubMed Web of Science ®Google Scholar
• WuWXingLZhouBLinZActive protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coliMicrob Cell Fact201110921320350
   PubMed Web of Science ®Google Scholar